Search - tctmd.com

Displaying 181 - 200 of 376

Sort: Relevancy | Date

Presentation THT 2023

Revivent TC® Procedure Planning and Anchor Placement Strategies

Presenter: Patrick Klein

March 21, 2023

Presentation THT 2023

Revivent TC® Patient Screening and Monitoring GDMT Response

Presenter: Michael Pfeiffer

March 21, 2023

Presentation THT 2023

The Revivent TC® Patient Phenotype

Presenter: Joggy George

March 21, 2023

Presentation THT 2023

A Left Ventricular Transcatheter Repair Device for HFrEF Patients: FIH Experience With the Vsling Device

Presenter: Gregg Stone

March 21, 2023

Presentation THT 2023

First-in-Human and Early Feasibility Study of Transcatheter Left Ventricular Myocardial Injection of Alginate Hydrogel in Heart Failure Patients – the Deke XDROP System

Presenter: Scott Lim

March 21, 2023

Presentation THT 2023

Vsling, A Left Ventricular Transcatheter Repair Device for HFrEF Patients

Presenter: Boaz Manash

March 21, 2023

Presentation THT 2023

Left ventricular reconstruction compared to optimal medical therapy in patients with ischemic cardiomyopathy

Presenter: Oleg Polonetsky

March 21, 2023

Presentation THT 2023

Effect of Supersaturated Oxygen (SSO2) on Left Ventricular Ejection Fraction (LVEF) in LAD STEMI Patients Post PCI in the Real World: Retrospective Comparison to Control Patients

Presenter: Tyler Bonkowski

March 21, 2023

Presentation THT 2023

The Role of Guideline Directed Medical Therapy in Functional Improvement after Hybrid Left Ventricular Reconstruction for the Treatment of Ischemic Heart Failure

Presenter: Romy Hegeman

March 21, 2023

Presentation THT 2023

What Is the Potential Role of Shunts Across the Spectrum of LV EFs?

Presenter: Liviu Klein

March 21, 2023

Presentation THT 2023

What Are the Pros and Cons of the Win Ratio as the Primary Endpoint for Pivotal Heart Failure Trial

Presenter: Mandeep Mehra

March 20, 2023

Presentation THT 2023

What are the Strengths and Limitations of a Two-Phase (6-Month Intermediate Endpoints & 12-18 Month Mortality and Heart Failure Hospitalization) Trial Design

Presenter: William Abraham

March 20, 2023

Presentation THT 2023

FDA Introduction

Presenter: Changfu Wu

March 20, 2023

Presentation TCT 2022

A Left Ventricular Transcatheter Repair Device for HFrEF (Cardiac Success Vsling)

Presenter: Gregg W. Stone

September 19, 2022

Presentation TCT 2022

TCT 348: Evaluating improvement in regional left ventricular function after hybrid minimally invasive left ventricular reconstruction in ischemic cardiomyopathy: CT- or MRI-based inward displacement to overcome current shortcomings in imaging

Presenter: Romy Hegeman

September 18, 2022

Presentation TCT 2022

TCT 346: Safety of right and left ventricular endomyocardial biopsy in Heart Transplant and Cardiomyopathy patients

Presenter: Konstantinos Bermpeis

September 18, 2022

Presentation TCT 2022

TCT 104: Impact of Left Ventricular Ejection Fraction (EF) on 10-year Mortality after Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Grafting (CABG) : Is CABG Safer Than PCI in all Patients With Reduced Ejection Fraction (rEF) ?

Presenter: Patrick Serruys

September 18, 2022

Presentation TCT 2022

TCT 48: Left Ventricular Recovery Among Patients With Acute Anterior ST-Elevation Myocardial Infarction Treated With Impella

Presenter: Adrian Attinger-Toller

September 17, 2022

Presentation TCT 2022

TCT 67: Modification of the Impella Device for Instantaneous Determination of Native Left Ventricular Cardiac Output and Volume

Presenter: Imran Aslam

September 17, 2022

Advertisement

Revivent TC® Procedure Planning and Anchor Placement Strategies

Revivent TC® Patient Screening and Monitoring GDMT Response

The Revivent TC® Patient Phenotype

A Left Ventricular Transcatheter Repair Device for HFrEF Patients: FIH Experience With the Vsling Device

First-in-Human and Early Feasibility Study of Transcatheter Left Ventricular Myocardial Injection of Alginate Hydrogel in Heart Failure Patients – the Deke XDROP System

Vsling, A Left Ventricular Transcatheter Repair Device for HFrEF Patients

Left ventricular reconstruction compared to optimal medical therapy in patients with ischemic cardiomyopathy

Effect of Supersaturated Oxygen (SSO2) on Left Ventricular Ejection Fraction (LVEF) in LAD STEMI Patients Post PCI in the Real World: Retrospective Comparison to Control Patients

The Role of Guideline Directed Medical Therapy in Functional Improvement after Hybrid Left Ventricular Reconstruction for the Treatment of Ischemic Heart Failure

What Is the Potential Role of Shunts Across the Spectrum of LV EFs?

What Are the Pros and Cons of the Win Ratio as the Primary Endpoint for Pivotal Heart Failure Trial

What are the Strengths and Limitations of a Two-Phase (6-Month Intermediate Endpoints & 12-18 Month Mortality and Heart Failure Hospitalization) Trial Design

FDA Introduction

A Left Ventricular Transcatheter Repair Device for HFrEF (Cardiac Success Vsling)

TCT 348: Evaluating improvement in regional left ventricular function after hybrid minimally invasive left ventricular reconstruction in ischemic cardiomyopathy: CT- or MRI-based inward displacement to overcome current shortcomings in imaging

TCT 346: Safety of right and left ventricular endomyocardial biopsy in Heart Transplant and Cardiomyopathy patients

TCT 104: Impact of Left Ventricular Ejection Fraction (EF) on 10-year Mortality after Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Grafting (CABG) : Is CABG Safer Than PCI in all Patients With Reduced Ejection Fraction (rEF) ?

TCT 48: Left Ventricular Recovery Among Patients With Acute Anterior ST-Elevation Myocardial Infarction Treated With Impella

TCT 67: Modification of the Impella Device for Instantaneous Determination of Native Left Ventricular Cardiac Output and Volume

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content